• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Yale University

Headquarters: New Haven, CT, United States
Website: http://www.yale.edu
Year Founded: 1701
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jan 27, 2025
Discovery & Translation

Science Spotlight: Improving safety of live-attenuated vaccines

BioCentury’s roundup of translational innovations also includes base editing for prion disease, a Flagship collab, and six papers with links to newcos
Read More
BioCentury | Nov 13, 2024
Discovery & Translation

Science Spotlight: How extrachromosomal DNA drives cancer

BioCentury’s roundup of translational innovation features two trios of papers: one on genetic control of cancer and the other on MASLD markers
Read More
BioCentury | Oct 31, 2024
Discovery & Translation

Science Spotlight: Macrophage-fibroblast cross-talk in heart failure

BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
Read More
BioCentury | Oct 24, 2024
Product Development

Vaderis: A case study in navigating the orphan drug development maze

Company went from idea to clinical proof of concept for
Read More
BioCentury | Oct 3, 2024
Discovery & Translation

Type 2 cytokines for durable cancer remission, drugging GTPases: BioCentury’s Science Spotlight

BioCentury’s roundup of translational innovations
Read More
BioCentury | Aug 30, 2024
Discovery & Translation

Science Spotlight: Roche’s intestinal immuno-organoids, cytokine METRNL’s role in tumors, and more

BioCentury’s roundup of translational innovations
Read More
BioCentury | Aug 15, 2024
Finance

Venture Report: Halda bringing RIPTACs into clinic with crossover round

Plus: Abata draws strategic investment from BMS as it preps first human study in multiple sclerosis
Read More
BioCentury | Aug 3, 2024
Deals

Biotechs find problem-solving in academia, and mostly outside the big hubs 

Academia-biotech deals span innovative assets to tissue bank resources to enabling technologies
Read More
BioCentury | May 31, 2024
Distillery Therapeutics

Inhibiting FABP5 for hepatocellular carcinoma

Read More
BioCentury | Apr 27, 2024
Discovery & Translation

Science spotlight: Tumor T cell restriction mechanism, plus programmable RNA excision

BioCentury’s roundup of translational innovations
Read More
Items per page:
1 - 10 of 515